A Phase 1b, open-label, dose escalation and expansion study evaluating the safety and efficacy of entospletinib (GS-9973) with vincristine and dexamethasone in adult subjects with relapsed or refractory acute lymphoid leukemia (ALL) Meeting Abstract
| Authors: | Minden, M. D.; Stock, W.; Crosswell, H.; Siegel, R. D.; Chun, P.; Abella, S.; He, J.; Eng, C.; Douer, D. |
| Abstract Title: | A Phase 1b, open-label, dose escalation and expansion study evaluating the safety and efficacy of entospletinib (GS-9973) with vincristine and dexamethasone in adult subjects with relapsed or refractory acute lymphoid leukemia (ALL) |
| Meeting Title: | 57th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 126 |
| Issue: | 23 |
| Meeting Dates: | 2015 Dec 5-8 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2015-12-03 |
| Language: | English |
| ACCESSION: | WOS:000368021803169 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V126.23.4866.4866 |
| Notes: | Meeting Abstract: 4866 -- 57th Annual Meeting of the American-Society-of-Hematology -- DEC 05-08, 2015 -- Orlando, FL -- Source: Wos |
